(Date:5/16/2008)...ustomer thought leaders -, SAN FRANCISCO, May 16 ... and trusted resource for clinical trial managemen...tigious academic medical centers, research,institu...up meeting in San,Francisco. The Velos eResearch s...tively manage thousands of clinical trials., Over...
(Date:5/16/2008)...strating that TYKERB and trastuzumab together resu...ession-free survival (PFS), -- Combining TYKERB a...de of the HER2 receptor may create a more complete... TYKERB alone despite patients,previous treatment...py, LONDON and PHILADELPHIA, May 16 /PRNewswire-U...
(Date:5/16/2008)...Veridex, LLC announced today that,its licensing co...ings,(LabCorp), has commercially launched a new ge...ssay uses the biological specificity of ,DNA,methy...ion of the gene,GST-Pi. Methylation is a modificat...x is developing the methylation markers in this ti...
(Date:5/15/2008)...lation Most Affected by Disease -, WAYNE, N.J. an.../ --,Bayer HealthCare Pharmaceuticals, Inc. and On...nounced that Nexavar(R) (sorafenib) tablets,signif...(HR=0.68;,p-value=0.014) in patients in the Asia-P...ma (HCC), or primary liver cancer versus those,rec...
Breaking Medicine Technology:Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 2Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 1BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 2BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 3Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference 602 1Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference 602 2Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference 602 3Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis 600 1Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis 600 2New Orthopedic Surgical Robotics Company Opens Its Doors 3B Files with the FDA for Clearance of Its Flagship Product 599 1New Orthopedic Surgical Robotics Company Opens Its Doors 3B Files with the FDA for Clearance of Its Flagship Product 599 2(Date:5/16/2008)...on abstracts or poster presentations at the annual...ogy (ASCO) to be held in Chicago, Illinois, May 30... Early Detection of Malignant Pleural Mesothelioma...arly detection and prognostic marker,in malignant...ey Pass, M.D., professor of cardiothoracic surgery...
(Date:5/16/2008)...promising drug formerly approved as a second line ...nhanced the effectiveness of hormonal therapy for ...st cancer, according to a Phase II clinical trial .... Anderson Cancer Center. , These findings are s...or Iressa in breast cancer, as well as for the ent...
(Date:5/16/2008)...ire-USNewswire/ -- RediStat,Corporation announced ...ency messaging services to its healthcare clients....king video communications service in,conjunction w... were made,by RediStat President, Michael Hemlepp,...ing held in Ft. Lauderdale., "We are very pleased...
(Date:5/16/2008).../ -- Tao Formulations announces the,official launc...e Internal,Medicine 2008 conference in Washington ...of years of research to develop a safe, all-natura...lieving menopausal symptoms., Company founder and...n,and gynecologist, founded Tao Formulations (htt...
Breaking Medicine News(10 mins):Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 4Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 2Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 3Health News:RediStat Corporation Partners With ALERT FM for Disaster-Proof Emergency Communications 2Health News:Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula 2... around the world are gathering in the West Africa...ed to claim 1,00,000 African lives every year. Po... as 'African Trypanosomiasis', the disease is carr...ing in Tsetse fly-endemic areas of west and centra...
..., a highly addictive stimulant drug, whose abuse h...he world, causes long-term changes in the human br...otor coordination, according to a study published ...s found that these effects are seen even in metham...
...s like it could be making healthy people with no h...prescribed to more than 38 million people world-wi...ies biggest success stories of recent years. Proza... SSRIs (selective serotonin reuptake inhibitors). ...
...new survey, it is found that doctors are prescribi...e throat is the second most common symptom sending...s caused by a virus and will not respond to antibi...ospital and the Stanford Center for Research in Di...
Other Medicine News:Health News:Drug abuse leads to long standing changes in the brain 2Health News:Drug abuse leads to long standing changes in the brain 3Health News:Wonder drug - could end in disaster 2A Merger of True Equals,Symbia T6, a True Point SPECTCT system, combines a dual-detector variable angle gamma camera with a six-slice CT scanner for advanced oncology, neurology, and cardiology app
...stent technology with no compromises. It's the ste... results. With S670's discrete, low-profile delive...excellent clinical results you want. S670, the fir...es. It's the stent that delivers like a balloon-wi...
The balloon catheter is a coaxial, dual balloon design and is made of PEBAX Material. Gas is contained in the inner balloon enhancing procedural safety. Radiopaque markings enhance the visibility of
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters.
Medicine Products: